Current assays for quantification of HIV-1 virions rely real-time RT-PCR detection 17 of conserved regions of HIV-1 RNA and can be limited by detection of contaminating 18 viral or plasmid DNA. We developed a novel RT-PCR assay using a reverse primer 19 that hybridizes with the poly(A) tail of HIV-1 mRNAs, anchored by conserved viral 20 nucleotides at the most distal region of the transcript. This assay can detect and 21 quantify HIV-1 RNA with high specificity and sensitivity. 22 23 on July 9, 2017 by guest
Quantifying virions is important in HIV-1 management and basic research (1-8). 24
Virions are generally quantified using real-time reverse transcriptase (RT)-PCR 25 amplification of genomic RNA with primers in a conserved region such as gag (9-11). 26
A limitation is lack of specificity because, in principle, any RNA or DNA containing the 27 relevant sequence can be amplified, including integrated or unintegrated viral DNA, 28
and, in transfection studies, plasmids containing HIV-1 sequences. Amplification of 29 DNA templates is apparent from positive no-RT controls but nevertheless complicates 30 quantification. In the analysis of HIV-1 RNA in cells, conventional RT-PCR assays also 31 can detect aberrant RNAs such as chimeric host-virus transcripts originating from 32 upstream host promoters (12, 13) and truncated or prematurely terminated viral 33 transcripts (14-17). Another assay for virions, the enzyme linked immunosorbent 34 assay (ELISA) detecting HIV-1 Gag p24, has low sensitivity (10 3 -10 6 virus particles/ml) 35 and can also detect virus-like particles lacking genomic RNA and p24 released from 36 dead cells (18) (19) (20) (21) . 37
Here we report a new method to quantify virus production and gene expression 38 based on a feature shared by genomic HIV-1 RNA and all spliced HIV-1 RNAs but not 39 aberrant RNAs, integrated or unintegrated proviral DNA, or recombinant plasmids 40 containing HIV-1 sequences. Since all HIV-1 mRNAs including genomic RNA have a 41 poly(A) tail, we hypothesized that PCR with oligo-dT-containing downstream primers 42 should allow specific amplification of cDNA generated by reverse transcription of viral 43 mRNA ( Figure 1A) . Therefore, HEK293T cells were transfected with the proviral clone 44 pNL4-3, and the viruses produced were collected to extract genomic viral RNA. 45
After reverse transcription using random hexamers as primers, viral RNA was 46 amplified with primers Tmix and P9285 (Supplemental Table 1 ). The amplicon 47 nucleotides complimentary to the 3' end of the R region gave better amplification than 68 a primer containing only 3 complimentary nucleotides (3T23) or a primer with 30 dTs. 69
Regarding specificity, 10 6 copies of pVQA were detected after 20 cycles using each of 70 the oligo-dT-containing primers, while10
6 copies of pNL4-3 were detected only with 71 10T20 or 7T23 and only after 38.5 or 31.4 cycles, respectively ( Figure 2B ). Thus, 72 primers with <7 nucleotides complimentary to the 3' end of the R region specifically 73 amplify poly(A)-containing templates rather than proviral DNA. Primer 5T25 provided 74 the best balance between sensitivity and specificity. With 5T25, 10 copies of pVQA 75 could be readily detected while ≥10 6 copies of pNL4-3 were required ( Figure 2C ). We 76 used a standard (22) containing precisely determined numbers of HIV-1 virions to 77 evaluate the accuracy and sensitivity of this assay. The standard was serially diluted 78 prior to genomic viral RNA extraction and real-time RT-PCR with 5T25. As few as 100 79 copies of genomic viral RNA could be detected ( Figure 3A ). To determine whether this 80 assay could accurately measure viruses in patient samples, especially from the 81 plasma of patients on HAART whose plasma HIV-1 RNA levels are <50 copies/ml, we 82 performed a direct comparison between this assay and single copy assay that has 83 become the definitive assay for residual viremia in patients on HAART whose plasma 84 HIV-1 RNA levels are below the limit of detection of the clinical assay (10, 23). We 85
show that this novel assay can sensitively and accurately quantitate patient viruses 86 both in the supernatants of positive culture wells in viral outgrowth assays and directly 87 in patient plasma ( Figures 3B, 3C and 3E ). However, this assay does require larger 88 input of HIV-1 RNA than single copy assay because we failed to detect HIV-1 RNA by 89 this assay when less than 9 ml patient plasma was used ( Figure 3D ), which was 90 probably due to the low Tm value of oligo-dT-containing primers. Copy numbers of 91 viral RNA obtained with this assay are 1.5 to 3 fold lower than those measured by 92 single copy assay, probably because plasmid DNA is used to generate standard curve, 93 and this does not take into account inefficiency in RNA isolation and reverse 94 transcription. In addition, the presence of terminally truncated genomic RNA with an 95 intact packaging signal may also contribute to the difference in copy numbers 96 measured by these two assays. Therefore, we suggest using RNA standard for 97 precise measurement, e.g. HIV-1 RNA levels in patient plasma, and using DNA 98 standard for rapid and relative quantitation, e.g. intracellular viral RNA in the latent 99
reservoir. 100
To illustrate measurement of virus production with this assay, unstimulated 101 
CD4
+ T cells ( Figure 4A ). As a control, we used a budding-deficient virus 106 NL4-3-Δ6-drGFP. Following infection, viral mRNAs were produced as evidenced by 107 GFP expression. However, a premature stop codon in gag prevents virus production. 108
The burst size was <10 viruses/cell/day for both activated and unstimulated cells. 109
All spliced HIV-1 mRNAs contain a 3' sequence identical to that of genomic viral 110 RNA and could in principle be detected using oligo-dT-containing primers ( Figure 4B ). 111 on July 9, 2017 by guest http://jvi.asm.org/
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Although spliced transcripts are not specifically incorporated into virions due to the 112 lack of a packaging signal (25), it was important to determine whether random 113 incorporation of spliced transcripts affects measurement of genomic viral RNA. 114
Therefore, primers P9501 and 5T25 were used to measure total viral RNA in 115 supernatants from infected Jurkat cells. Spliced transcripts were quantified using 116 gene specific primers (Supplemental Table 1 , Figure 4B ). As shown in Figure 4C , vif, 117 vpr, and tat mRNAs represent only 0.5%, 0.4% and 2.5% of the total virion RNA, 118 respectively. Thus spliced RNAs do not substantially affect the measurement of virus 119 production using this assay in cell line models of HIV-1 infection. 120
In conclusion, this viral quantification assay using oligo-dT-containing primers 121 oligo-dT containing primers. Serial dilutions of pVQA from 3*10 6 to 3*10 1 copies were 253 used as template. Each oligo-dT containing primer (Supplemental Table 1 
